BG64541B1 - Фармацевтични състави,съдържащи ламивудин и зидовудин, и използването им - Google Patents
Фармацевтични състави,съдържащи ламивудин и зидовудин, и използването им Download PDFInfo
- Publication number
- BG64541B1 BG64541B1 BG103435A BG10343599A BG64541B1 BG 64541 B1 BG64541 B1 BG 64541B1 BG 103435 A BG103435 A BG 103435A BG 10343599 A BG10343599 A BG 10343599A BG 64541 B1 BG64541 B1 BG 64541B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- pharmaceutically acceptable
- pharmaceutical composition
- lamivudine
- zidovudine
- amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9622681.6A GB9622681D0 (en) | 1996-10-31 | 1996-10-31 | Pharmaceutical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
BG103435A BG103435A (en) | 2000-04-28 |
BG64541B1 true BG64541B1 (bg) | 2005-07-29 |
Family
ID=10802224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG103435A BG64541B1 (bg) | 1996-10-31 | 1999-05-26 | Фармацевтични състави,съдържащи ламивудин и зидовудин, и използването им |
Country Status (44)
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
GB9809213D0 (en) * | 1998-04-29 | 1998-07-01 | Glaxo Group Ltd | Pharmaceutical compositions |
US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
EP1501521B1 (en) * | 2002-04-23 | 2007-05-02 | Lupin Limited | Long acting compositions comprising zidovudine and/or lamivudine |
WO2004043433A2 (en) * | 2002-11-08 | 2004-05-27 | Glaxo Group Limited | Pharmaceutical antiviral compositions |
EP3025718A1 (en) | 2003-01-14 | 2016-06-01 | Gilead Sciences, Inc. | Compositions and methods for combination antiviral therapy |
AR045841A1 (es) * | 2004-09-28 | 2005-11-16 | Richmond Sa Com Ind Y Financie | Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla. |
US20130115237A1 (en) | 2010-06-09 | 2013-05-09 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment |
JP2015509524A (ja) | 2012-03-05 | 2015-03-30 | シプラ・リミテッド | ラミブジン、フェスティナビルおよびネビラピンを含んでなる抗レトロウイルス医薬組成物 |
US20140234415A1 (en) * | 2013-02-20 | 2014-08-21 | Abbvie Inc. | Tablet Dosage Forms |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950652A (en) * | 1987-03-23 | 1990-08-21 | Hem Research, Inc. | dsRNAs for combination therapy in the treatment of viral diseases |
CZ285232B6 (cs) * | 1991-05-16 | 1999-06-16 | Glaxo Group Limited | Protivirové směsi |
GB9110624D0 (en) * | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Combinations |
GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1996
- 1996-10-31 GB GBGB9622681.6A patent/GB9622681D0/en active Pending
-
1997
- 1997-10-24 HR HR970569A patent/HRP970569B1/xx not_active IP Right Cessation
- 1997-10-28 SV SV1997000090A patent/SV1997000090A/es not_active Application Discontinuation
- 1997-10-28 MY MYPI97005103A patent/MY119513A/en unknown
- 1997-10-28 CO CO97063174A patent/CO4930269A1/es unknown
- 1997-10-29 NZ NZ335153A patent/NZ335153A/en unknown
- 1997-10-29 CZ CZ0155799A patent/CZ296080B6/cs not_active IP Right Cessation
- 1997-10-29 BR BR9712614-4A patent/BR9712614A/pt not_active IP Right Cessation
- 1997-10-29 IL IL12942297A patent/IL129422A0/xx not_active IP Right Cessation
- 1997-10-29 DE DE69722433T patent/DE69722433T2/de not_active Expired - Lifetime
- 1997-10-29 ZA ZA979726A patent/ZA979726B/xx unknown
- 1997-10-29 SK SK575-99A patent/SK284286B6/sk unknown
- 1997-10-29 DK DK97950036T patent/DK0941100T3/da active
- 1997-10-29 EE EEP199900175A patent/EE03806B1/xx not_active IP Right Cessation
- 1997-10-29 ES ES97950036T patent/ES2200204T3/es not_active Expired - Lifetime
- 1997-10-29 WO PCT/EP1997/005953 patent/WO1998018477A2/en active IP Right Grant
- 1997-10-29 JP JP10520045A patent/JP2001502718A/ja active Pending
- 1997-10-29 AT AT97950036T patent/ATE241364T1/de active
- 1997-10-29 CA CA002270174A patent/CA2270174A1/en not_active Abandoned
- 1997-10-29 AU AU53142/98A patent/AU736607B2/en not_active Ceased
- 1997-10-29 EA EA199900345A patent/EA002437B1/ru not_active IP Right Cessation
- 1997-10-29 UA UA99042239A patent/UA64725C2/uk unknown
- 1997-10-29 PT PT97950036T patent/PT941100E/pt unknown
- 1997-10-29 AP APAP/P/1999/001519A patent/AP1067A/en active
- 1997-10-29 HU HU0000344A patent/HU224969B1/hu not_active IP Right Cessation
- 1997-10-29 AR ARP970105027A patent/AR009135A1/es unknown
- 1997-10-29 PL PL97333143A patent/PL190349B1/pl unknown
- 1997-10-29 YU YU19999A patent/YU19999A/sh unknown
- 1997-10-29 GE GEAP19974781A patent/GEP20022735B/en unknown
- 1997-10-29 KR KR1019997003757A patent/KR100551652B1/ko not_active IP Right Cessation
- 1997-10-29 TR TR1999/00950T patent/TR199900950T2/xx unknown
- 1997-10-29 EP EP97950036A patent/EP0941100B1/en not_active Expired - Lifetime
- 1997-10-29 SI SI9730570T patent/SI0941100T1/xx unknown
- 1997-10-29 PE PE1997000965A patent/PE10099A1/es not_active Application Discontinuation
- 1997-10-29 GT GT199700116A patent/GT199700116A/es unknown
- 1997-10-30 PA PA19978441101A patent/PA8441101A1/es unknown
- 1997-10-30 ID IDP973554A patent/ID18698A/id unknown
- 1997-10-30 UY UY24766A patent/UY24766A1/es not_active IP Right Cessation
-
1999
- 1999-04-09 IS IS5024A patent/IS5024A/is unknown
- 1999-04-23 OA OA9900088A patent/OA11038A/en unknown
- 1999-04-29 NO NO19992091A patent/NO317163B1/no unknown
- 1999-05-26 BG BG103435A patent/BG64541B1/bg unknown
- 1999-12-24 HK HK99106129A patent/HK1020880A1/xx not_active IP Right Cessation
-
2004
- 2004-11-26 CY CY0400085A patent/CY2485B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2633603C (en) | Pharmaceutical combination | |
US6113920A (en) | Pharmaceutical compositions | |
HUE035241T2 (en) | Darunavir combination products | |
CA2330391A1 (en) | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine | |
BG64541B1 (bg) | Фармацевтични състави,съдържащи ламивудин и зидовудин, и използването им | |
KR20200070246A (ko) | 이중층 제약 정제 제제 | |
EP1567133B1 (en) | Pharmaceutical antiviral compositions | |
US20050171127A1 (en) | Pharmaceutical compositions comprising abacavir and lamivudine | |
MXPA99004025A (en) | Pharmaceutical compositions containing lamivudine and zidovudine | |
US20050113394A1 (en) | Pharmaceutical compositions | |
WO2022132676A1 (en) | Mini-tablet dosage form of a viral terminase inhibitor and uses thereof | |
MXPA00010498A (en) | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine | |
CZ20003998A3 (cs) | Farmaceutický prostředek |